NATUREX : Steady revenue in Q1 2017

2017 first-quarter revenue and financial information (1 January to 31 March 2017)

Steady revenue in Q1 2017

Press release

Avignon, 12 May 2017 - Naturex, the global leader in speciality plant-based natural ingredients, announces its 2017 first-quarter consolidated revenue and financial information:

In €m

IFRS

(Unaudited data)
1^st quarter

2017
1^st quarter

2016
Change (%)


 
 
 
Current exchange

rates
Constant exchange

rates


Revenue
104.4
104.4
0.0%
-1.8%


Recurring operating EBITDA
15.8
15.7
+0.6%
 


Recurring operating EBITDA margin (%)
15.1%
15.0%
 
 

2017 first quarter revenue amounted to €104.4 million, in line with the same period in 2016, including a positive currency effect¹.

Recurring operational EBITDA on that basis came to €15.8 million, representing a margin of 15.1%.

“As announced when the 2016 annual results were published, 2017 first quarter revenue remained steady in relation to last year's same period. In accordance with our implementation plan, we concentrated on optimising our product mix by shifting its focus to our four strategic categories, while initiating the final phase in reducing the number of SKUs and accelerating the adoption of simplification measures.

Geographically, our regional organisation enabled us to target and adapt our approach to the diverse characteristics and volatility of our markets. In this way, we continued to benefit from opportunities provided by dynamic emerging countries whereas our strong position in North America confirmed our capacity for getting back on track for growth, particularly in the nutraceutical sector. In Europe, comparison base effects and the accelerating rationalisation in the number of SKUs masked the positive effects from certain product categories.

Finally, our teams' ongoing efforts to reduce operating expenses and increase operating efficiencies have bolstered our current operating margin.

As we begin 2017 with confidence, our priorities in the first half are clearly focused on accelerating the simplification measures and in the second half on top line growth and operating profitability."

Olivier Rigaud, Chief Executive Officer and Director of Naturex

Revenue by business

 €m - IFRS

(Unaudited data)
1^st quarter

2017
1^st quarter

2016
Revenue mix (%)
Change (%)


 
 
 
 
Current exchange

rates
Constant exchange

rates


My Natural Food
53.9
53.1
51.7%
+1.6%
+0.7%


My Natural Selfcare
36.3
37.0
34.7%
-2.1%
-4.9%


Other activities
14.2
14.3
13.6%
-0.7%
-3.1%


TOTAL
104.4
104.4
100.0%
0.0%
-1.8%

 

Revenue by region

 €m - IFRS

(Unaudited data)
1^st quarter

2017
1^st quarter

2016
Revenue mix (%)
Change (%)


 
 
 
 
Current exchange

rates
Constant exchange

rates


Europe/Africa/Middle East
34.6
39.4
33.1%
-12.3%
-11.2%


North America,
46.3
45.1
44.4%
+2.7%
-0.2%


Latin America
8.0
6.3
7.6%
+25.8%
+22.0%


Asia/Pacific
15.5
13.6
14.9%
+14.5%
+9.0%


TOTAL
104.4
104.4
100.0%
0.0%
-1.8%

A conference call will be held on 12 May 2017 at 6:00 p.m.

A webcast of the presentation will be available live and by retransmission from the following link:

• Access to the webcast from a computer
  
  To access the live or replay version of this webcast from a computer, click on: http://edge.media-server.com/m/p/eky5d8gt


• Access to the webcast from a mobile device - QR code
  
  To access the live or replay version of this webcast from mobile phones or tablet devices using iOS and android operating systems:

You can receive all financial information of Naturex free of charge by signing up at: www.naturex.fr

• Financial schedule

 
2017 H1 revenue
31 July 2017

• Upcoming events

 
AGM (Paris)
20 June 2017

---

About Naturex

Naturex sources, manufactures and markets natural speciality ingredients for the food, health and cosmetic industries. As the Natural Maker, the company actively supports the global shift from synthetic to natural through an offer built on two main focus areas: My Natural Food and My Natural Selfcare. Naturex's portfolio includes colours, antioxidants, speciality fruits & vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to create healthy, authentic and effective products.

The Group's strong commitment to quality, sustainability, continuous innovation process, and the talent of its people are at the heart of its success.

Headquartered in Avignon, France, Naturex has experienced steadily-increasing growth throughout the last 25 years. The Group had revenue of €404.4 million in 2016 and employs 1,700 people worldwide.

The Group is listed on Euronext Paris, Compartment B – Index: Euronext Next 150, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa - Ticker: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY

 NATUREX, From Nature to You

• Contacts

 


Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]

---

Receive by email the next press releases of the company by registering on
www.actusnews.com, it's free

Source: Actusnews